No products in the cart.
CBD nutraceuticals in Switzerland – a market with a future
The market for CBD nutraceuticals in Switzerland is growing rapidly and offers enormous potential both economically and socially. More and more consumers are turning to natural dietary supplements containing cannabidiol (CBD), particularly to support well-being, stress reduction and sleep quality.
In 2024, the market volume in Switzerland will be around USD 187.4 million, with an impressive growth forecast of USD 487.7 million by 2030. This corresponds to a compound annual growth rate (CAGR) of 15.1% – which is above the European average.
The most sought-after products are currently CBD tinctures, followed by capsules and gummies, with CBD capsules and softgels in particular showing the highest growth potential. The Swiss market is also benefiting from an open regulatory environment, growing health awareness and a strong positioning in the premium segment.
Important market drivers
- Growing demand for plant-based, natural alternatives
- Better access through reforms and a clear legal situation in Switzerland
- Combination of bricks-and-mortar retail and growing online sales
Overall, Switzerland is positioning itself as one of the most dynamic markets for CBD nutraceuticals in Europe – ideal for innovation, quality and sustainable growth.
Source:
Grand View Research – CBD Nutraceuticals Market Outlook – Switzerland, 2025
www.grandviewresearch.com
